Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 80 subsidiaries and 170 offices and sites, with over 8,600 employees across 51 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibility for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Lake Bleu ... | lakebleu-c... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 10.08.2020 | HANGZHOU T... | I T G ME R E D 01 TIGE... | - | - | marketscre... |